ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,715Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 117

$1.73M Total Retail Price of All Prescriptions

Rank: 9 out of 117

514 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 514 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

26% of this provider’s 514 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 20,721 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 887 648 1 2
METOPROLOL TARTRATE 787 571 2 8
LEVOTHYROXINE SODIUM 747 629 3 1
FUROSEMIDE 706 596 4 4
TRAMADOL HCL 673 540 5 19
DONEPEZIL HCL 666 644 6 10
AMLODIPINE BESYLATE 634 548 7 5
LISINOPRIL 590 498 8 6
CYMBALTA 564 353 9 27
MIRTAZAPINE 560 515 10 14
NAMENDA 548 538 11 7
RISPERIDONE 545 424 12 35
HYDROCODONE-ACETAMINOPHEN 523 365 S3 13 3
OMEPRAZOLE 498 421 14 9
TRAZODONE HCL 467 350 15 23
WARFARIN SODIUM 378 310 16 13
POTASSIUM CHLORIDE 371 308 17 11
GABAPENTIN 308 223 18 12
QUETIAPINE FUMARATE 304 238 19 20
METFORMIN HCL 282 192 20 15
SERTRALINE HCL 281 229 21 16
CLOPIDOGREL 276 223 22 30
DIVALPROEX SODIUM 248 191 23 37
LACTULOSE 234 190 24 65
NOVOLIN R 226 177 25 40
HYDRALAZINE HCL 209 168 26 50
NOVOLOG 206 156 27 60
ZOLPIDEM TARTRATE 205 139 28 24
CARVEDILOL 203 180 29 22
PANTOPRAZOLE SODIUM 197 160 30 39
EXELON 194 185 31 34
FAMOTIDINE 189 137 32 49
PLAVIX 188 154 33 41
ATORVASTATIN CALCIUM 186 153 34 21
TAMSULOSIN HCL 183 153 35 31
LANTUS 178 163 36 25
LOSARTAN POTASSIUM 178 145 36 32
DIVALPROEX SODIUM ER 176 99 38 83
LIDODERM 172 137 39 62
ESCITALOPRAM OXALATE 171 150 40 29
METOPROLOL SUCCINATE 168 146 41 17
LEVOFLOXACIN 166 130 42 55
ABILIFY 164 86 43 75
ALBUTEROL SULFATE 161 113 44 68
LEVETIRACETAM 157 44 45 46
ALENDRONATE SODIUM 152 140 46 26
CLONIDINE HCL 148 90 47 52
SANTYL 143 114 48 100
HYDROCHLOROTHIAZIDE 142 128 49 28
IPRATROPIUM-ALBUTEROL 141 111 50 59
BENZTROPINE MESYLATE 140 128 R 51 97
SPIRIVA 140 121 51 80
ISOSORBIDE MONONITRATE ER 137 121 53 48
METOCLOPRAMIDE HCL 134 83 54 91
DIGOXIN 131 114 55 45
GLIPIZIDE 127 82 56 51
LEVEMIR 127 93 56 107
ADVAIR DISKUS 126 97 58 71
BACLOFEN 124 22 59 74
GLYBURIDE 123 93 R 60 108
PROMETHAZINE HCL 122 95 R 61 77
CITALOPRAM HBR 117 96 62 18
GEMFIBROZIL 115 72 63 150
MELOXICAM 113 85 64 70
BUSPIRONE HCL 109 80 65 105
RAMIPRIL 107 107 66 63
DIOVAN 106 96 67 38
MUPIROCIN 103 77 68 113
KLOR-CON M10 103 99 68 76
CARBIDOPA-LEVODOPA 102 85 70 53
NYSTATIN 101 66 71 81
OLANZAPINE 101 73 71 67
IPRATROPIUM BROMIDE 98 72 73 93
SEROQUEL 98 78 73 57
NIFEDIPINE ER 97 86 75 116
KLOR-CON M20 93 59 76 54
CEFTRIAXONE 92 79 77 129
PREDNISONE 90 70 78 47
HYDROXYZINE HCL 89 64 R 79 175
PHENYTOIN SODIUM EXTENDED 89 49 79 96
FLUTICASONE PROPIONATE 87 63 81 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 54 81 79
SPIRONOLACTONE 85 62 83 69
ATENOLOL 83 72 84 42
RANITIDINE HCL 81 47 85 43
SINGULAIR 77 64 86 99
CLONIDINE 76 57 87 136
LYRICA 73 42 88 73
OXYBUTYNIN CHLORIDE ER 72 67 89 85
CYCLOBENZAPRINE HCL 71 52 R 90 110
BUPROPION HCL SR 71 52 90 183
PAROXETINE HCL 69 38 92 82
ROPINIROLE HCL 66 56 93 89
SEROQUEL XR 66 58 93 189
JANUVIA 66 41 93 88
LATANOPROST 66 65 93 84
LIDOCAINE HCL 66 57 93 125
VALPROIC ACID 65 46 98 147
TRANSDERM-SCOP 65 33 98 217
HUMALOG 64 37 100 137
ALLOPURINOL 64 62 100 66
AMOX TR-POTASSIUM CLAVULANATE 64 48 100 102
DILTIAZEM HCL 64 47 100 177
POLYETHYLENE GLYCOL 3350 64 45 100 61
NOVOLIN N 62 45 105 172
GLUCAGEN 62 51 105 186
ENALAPRIL MALEATE 61 58 107 72
PRAVASTATIN SODIUM 60 45 108 33
NYSTOP 59 42 109 173
AMIODARONE HCL 57 38 110 98
CILOSTAZOL 55 50 111 139
PRIMIDONE 54 54 112 179
TRAVATAN Z 53 51 113 104
PROPRANOLOL HCL 52 31 114 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.